Mewburn Ellis LLP

Life Sciences

Managing Partner, Patent Attorney, Litigator

Richard is our Managing Partner and is responsible for leading the Management Board to devise and deliver the firm's strategy.

Richard has extensive experience in the biotechnology and pharmaceutical sectors.  He works closely with clients to establish a compelling commercial IP position.  Richard and his team help clients to generate active and valuable patent portfolios, defending key patents on a global basis, conducting freedom to operate analyses and taking effective action against competitors.

Areas of Expertise

Oligonucleotide technology, including aptamers, antisense and RNA interference. Richard succeeded in obtaining grant of the very first aptamer (SELEX) technology patents in Europe, and has unrivalled experience in this field. Adoptive T cell therapies, including CAR-T and VSTs. Antibodies Oncolytic viruses

Richard’s clients include biotechnology companies in Europe, the US and Singapore. Richard works closely with many clients based in Singapore and is a regular visitor.

He joined Mewburn Ellis LLP in 2003, qualifying as a Chartered Patent Attorney and European Patent Attorney in 2006, and was awarded a Higher Courts Litigation Certificate in 2015. He joined the partnership in 2006.

Richard has an MA in biochemistry from the University of Cambridge and is a Chartered Biologist.